Mubarak Al-Abdullah Al-Jaber Al-Sabah Dialysis Center
Hawalli, Kuwait
Location status: Recruiting
NCT Number: NCT07361146
This randomized controlled trial aims to compare the effectiveness of two different timings of physical therapy for individuals undergoing hemodialysis: intradialytic (during dialysis) and pre-dialysis (before dialysis). The study seeks to determine which approach provides better improvements in physical function, quality of life, and biochemical outcomes such as hemoglobin and electrolyte levels.
A total of 72 adult participants with end-stage renal disease (ESRD) receiving hemodialysis will be randomly assigned to one of two groups. Both groups will receive standardized educational sessions on the benefits and safety of exercise before beginning the intervention. Participants in the intradialytic group will perform supervised exercises during their dialysis sessions, while those in the pre-dialysis group will complete similar exercises before their dialysis sessions. Each participant will undergo the intervention twice per week for 12 weeks.
Primary outcomes include physical function, assessed using the Six-Minute Walk Test and the Five Times Sit-to-Stand Test. Secondary outcomes include hemoglobin levels, electrolyte balance, and health-related quality of life measured by the KDQOL questionnaire. The study will be conducted at Mubarak Al-Abdullah Al-Jaber Al-Sabah Dialysis Center, Kuwait, following ethical approval from the Ministry of Health Research Ethics Committee.
The results are expected to inform best practices for integrating physical therapy into dialysis care to enhance the health, safety, and well-being of individuals undergoing hemodialysis.
Interested in participating?
Request Info21 year–65 year
All sexes
Interventional
Not applicable
Hawalli, Kuwait
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A structured physical therapy program including warm-up, strengthening, balance, and stretching exercises delivered either during or before hemodialysis sessions (twice weekly for 12 weeks).
Time frame: Baseline, every 4 weeks during the 3-month intervention period, and at 6-month follow-up
Assessment of functional exercise capacity by measuring the total distance walked in six minutes.
Time frame: Baseline, every 4 weeks during the 3-month intervention period, and at 6-month follow-up
Quality of life assessed using the Kidney Disease Quality of Life (KDQOL) questionnaire.
Time frame: Baseline, every 4 weeks during the 3-month intervention period, and at 6-month follow-up
Assessment of lower limb strength and functional mobility by measuring the time required to complete five sit-to-stand repetitions.
Time frame: Baseline, 4 weeks, 8 weeks, and 12 weeks
Measurement of hemoglobin concentration from blood samples.
Time frame: Baseline, 4 weeks, 8 weeks, and 12 weeks
Measurement of serum potassium concentration.
Time frame: Baseline, 4 weeks, 8 weeks, and 12 weeks
Measurement of serum sodium concentration obtained from routine blood samples.
Time frame: Baseline, 4 weeks, 8 weeks, and 12 weeks
Measurement of serum calcium concentration obtained from routine blood samples.
Time frame: Baseline, 4 weeks, 8 weeks, and 12 weeks
Measurement of serum phosphorus concentration obtained from routine blood samples.
Mohammad Arian
Other Gov
A Comparative Study of Intradialytic Versus Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial
Acronym: DIAL-PT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07464418
Chronic Disease, Chronic Kidney Disease
Pacitan, East Java, Indonesia
View Trial DetailsNCT07555327
Anuria, Chronic Disease
Bordj Bou Arreridj, Wilaya de Bordj Bou Arréridj, Algeria
View Trial DetailsNCT07545629
Chronic Disease, Chronic Kidney Disease, Stage IV (Severe)
Wuhu, Anhui, China
View Trial DetailsNCT01222234
Chronic Disease, Chronic Kidney Disease (CKD)
Kansas City, Kansas, United States
View Trial Details